Ellington Management Group’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-9,200
Closed -$465K 625
2019
Q3
$465K Buy
+9,200
New +$453K 0.08% 244
2018
Q1
Sell
-16,500
Closed -$705K 909
2017
Q4
$705K Buy
+16,500
New +$658K 0.12% 142
2017
Q2
Sell
-10,400
Closed -$443K 749
2017
Q1
$443K Buy
+10,400
New +$424K 0.02% 355
2016
Q1
Sell
-11,700
Closed -$453K 581
2015
Q4
$453K Buy
+11,700
New +$455K 0.16% 152
2015
Q3
Sell
-6,400
Closed -$244K 782
2015
Q2
$244K Buy
+6,400
New +$224K 0.06% 512
2015
Q1
Sell
-10,300
Closed -$275K 740
2014
Q4
$275K Buy
+10,300
New +$266K 0.09% 358
2013
Q4
Sell
-15,200
Closed -$314K 654
2013
Q3
$314K Buy
+15,200
New +$324K 0.06% 492

Other funds holding HOLX

Ellington Management Group's HOLX Position: Q4 2019 in Review

Ellington Management Group sold out of Hologic (HOLX) in Q4 2019, closing a stake of 9,200 shares — an estimated $465K sold.

Ellington Management Group first reported a position in HOLX in Q3 2013 and held it in 7 quarters. The position peaked at $705K in Q4 2017. 519 funds tracked by Wall St. Rank hold HOLX as of Q4 2019.

  • Ellington Management Group reported no remaining Hologic position as of Q4 2019 after selling out during the quarter.
  • Ellington Management Group sold 9,200 Hologic shares in Q4 2019, an estimated $465K.
  • Ellington Management Group first reported a position in Hologic in Q3 2013 and held it in 7 quarters.
  • Ellington Management Group's Hologic position peaked at $705K in Q4 2017.
  • 519 funds tracked by Wall St. Rank held Hologic as of Q4 2019.

Based on Ellington Management Group's 13F filing for Q4 2019, filed 14 Feb 2020.